Beckman Coulter Life Sciences has announced a collaboration agreement with Pillar Biosciences, which develops and distributes IVD and retrospective use (RUO) NGS testing solutions based on its proprietary SLIMamp technology, to help localise patient testing and optimise the selection of precision therapies for cancer patients.
Thousands of patients with heart failure will now be treated from home as the NHS expands its world-leading virtual wards scheme. The expansion means people can remain active and maintain their independence in their own home, while undergoing medical treatment.
Imaging firm Evident has launched the new FLUOVIEW FV4000 confocal laser scanning microscope and FV4000MPE multiphoton laser scanning microscope, designed to redefine scientific imaging by delivering higher precision, reduced noise and improved sensitivity, setting a new standard for image acquisition and data reliability.
Proscia, a leading provider of digital and computational pathology solutions, has earned ISO 27001 certification. This certification demonstrates the company’s compliance with one of the best-known information security management standards, giving customers added confidence in its products.
The government will meet its target to open 160 community diagnostic centres a year early, the Health and Social Care Secretary has announced. All 160 centres will be open by March 2024, a year ahead of the original March 2025 target - speeding up access to diagnostic tests and checks.
PocDoc has been chosen by Roche Diagnostics to participate in the acclaimed Startup Creasphere programme, which will pilot the firm’s cardiovascular diagnostics.
Jade Erwin explains Source LDPath’s new Health Economic Model, and how it can help NHS Trusts and laboratories understand the cost implications and benefits of investing in digital pathology.
Haier Biomedical – a brand synonymous with cold chain storage – has launched a comprehensive range of benchtop centrifuges. Using its extensive knowledge of temperature controlled sample handling and innovative approach to product design, the company has created three benchtop, high-speed refrigerated centrifuges offering industry-leading features.
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced it is taking forward its new ‘regulatory sandbox’, the AI-Airlock, that will provide a regulator-monitored virtual area for developers to generate robust evidence for their advanced technologies.
Four trusts in the Greater Manchester Pathology Network are working to deploy a Clinisys laboratory information management system (LIMS) in a way that will enable them to work more collaboratively and improve services for clinicians and patients. The four trusts will deploy a standardised, interfaced version of WinPath Enterprise to support collaboration and lay the foundation for further innovation.
Diagnostics firm LumiraDx has unveiled a new strategic collaboration with Everton in the Community - the official charity of Everton FC - to set up England’s first community-based heart and lung screening hub, set to go live this month.
Digital pathology and clinical AI firm Paige has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for Paige Lymph Node, an AI application used to detect breast cancer metastases in lymph node tissue. Paige Lymph Node is the first AI application of its kind to receive such designation from the FDA.
Beckman Coulter Life Sciences and single cell and spatial biology firm 10x Genomics, have announced a new partnership to expand automation solutions for single-cell assay workflows.
Thermo Fisher Scientific has reached an agreement with the board of directors of Olink, a next-generation proteomics solutions provider based in Sweden, to acquire the firm for $26 per share, valuing it at approximately $3.1 billion.
Clinisys Chief Marketing Officer Paul Jackson reveals the conversations Clinisys is having with new and potential customers at IBMS Congress, as well as looking ahead to the next 12 months for his company.